Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 56.31bn | 51.24bn | 47.52bn | 42.31bn | 40.59bn | 39.07bn |
| Cost of revenue | 10.22bn | 9.21bn | 8.49bn | 7.57bn | 7.38bn | 7.31bn |
| Research and development | 17.70bn | 15.14bn | 12.94bn | 12.15bn | 11.18bn | 10.54bn |
| Selling, general and administrative | 2.61bn | 3.51bn | 2.66bn | 2.28bn | 1.87bn | 3.66bn |
| Operating expenses | 33.44bn | 30.71bn | 27.08bn | 24.76bn | 23.24bn | 24.22bn |
| Operating income | 22.87bn | 20.54bn | 20.44bn | 17.56bn | 17.35bn | 14.85bn |
| Pre-tax income | 21.75bn | 21.66bn | 20.53bn | 18.38bn | 17.82bn | 15.11bn |
| Income tax | −5.02bn | 18.95bn | 2.20bn | 1.74bn | 2.13bn | 1.64bn |
| Net income | 26.77bn | 2.71bn | 18.34bn | 16.64bn | 15.69bn | 13.47bn |
| Earnings per share | 10.57 | 1.08 | 7.28 | 6.59 | 6.20 | 5.31 |
| Earnings per share, diluted | 10.44 | 1.05 | 7.14 | 6.43 | 6.03 | 5.16 |
| Weighted average shares | 2.53bn | 2.52bn | 2.52bn | 2.53bn | 2.53bn | 2.53bn |
| Weighted average shares, diluted | 2.56bn | 2.57bn | 2.57bn | 2.59bn | 2.60bn | 2.61bn |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 23.43bn | 35.87bn | 10.19bn | 12.01bn | 28.75bn | 43.89bn | 43.85bn | 32.05bn |
| Short-term investments | 57.75bn | 45.72bn |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 32.23bn | — | — | 24.03bn | — | — |
| Depreciation and amortisation | 6.00bn | — | — |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 34.26bn |
| 35.07bn |
| 41.48bn |
| 33.93bn |
| 27.05bn |
| 26.04bn |
| Receivables | 17.47bn | 19.77bn | 17.30bn | 16.56bn | 14.51bn | 16.99bn | 14.70bn | 14.51bn |
| Current assets | 109.77bn | 108.72bn | 73.12bn | 73.61bn | 90.23bn | 100.05bn | 91.07bn | 76.43bn |
| Goodwill | 24.75bn | 24.53bn | 21.16bn | 20.65bn | 20.65bn | 20.65bn | 20.65bn | 20.65bn |
| Total assets | 395.25bn | 366.02bn | 303.84bn | 294.74bn | 280.21bn | 276.05bn | 256.41bn | 230.24bn |
| Current liabilities | 46.75bn | 41.84bn | 36.96bn | 37.31bn | 33.89bn | 33.60bn | 33.33bn | 27.00bn |
| Long-term debt | 58.75bn | 58.74bn | 28.83bn | 28.83bn | 28.83bn | 28.83bn | 28.82bn | 18.39bn |
| Total liabilities | 151.57bn | 148.78bn | 109.78bn | 99.67bn | 95.18bn | 93.42bn | 91.88bn | 73.48bn |
| Equity | 243.68bn | 217.24bn | 194.07bn | 195.07bn | 185.03bn | 182.64bn | 164.53bn | 156.76bn |
| 3.90bn |
| — |
| — |
| Share-based compensation | 6.03bn | — | — | 4.15bn | — | — |
| Capital expenditure | 19.00bn | — | — | 12.94bn | — | — |
| Investing cash flow | −33.68bn | — | — | −20.01bn | — | — |
| Dividends paid | 1.35bn | 1.33bn | 1.33bn | 1.33bn | 1.26bn | 1.27bn |
| Share buybacks | 0 | — | — | 12.75bn | — | — |
| Financing cash flow | −6.55bn | — | — | −19.50bn | — | — |